BACKGROUND: Nutritional approaches are sought to overcome the limits of pioglitazone in
metabolic syndrome and non-alcoholic fatty liver disease. Spirulina, a filamentous …

Objective This study sought to investigate the effect of Spirulina on cardiometabolic risk
factors, oxidative stress biomarkers, glycemic profile, and liver enzymes in nonalcoholic fatty …

Non-alcoholic steatohepatitis (NASH) is characterized by an excess of lipids and oxidative
stress in the liver. Spirulina was reported to possess hypolipemic and antioxidative effects …

Spirulina is a cyanobacterium rich in proteins, polyunsaturated fatty acids, and bioactive
compounds, such as C-phycocyanin, which has anti-inflammatory and antioxidant properties …

Introduction Non-alcoholic fatty liver diseases range from simple steatosis to non-alcoholic
steatohepatitis. The" two hits" hypothesis is widely accepted for its pathogenesis: the first hit …

Obesity is characterized by abnormal or excessive fat accumulation that impairs health. In
this study, the effects of Spirulina lipids (SL) and fish oil (FO) on obesity and hepatic lipid …

Background In recent years, a great attention has been focused on Spirulina platensis as a
source of potential valuable nutrients for prevention and treatment of chronic diseases. The …

Aims The aim of this systematic review was to assess the effects of Spirulina
supplementation on metabolic syndrome components, its liver manifestation and related …

Purpose Spirulina is generally used as a nutraceutical food supplement due to its nutrient
profile, lack of toxicity, and therapeutic effects. Clinical trials have investigated the influence …

Aims Novel alternative treatments such as food supplements may be an effective approach
to weight management. The aim of the present study was to investigate the possible effects …